| Dr Teresa A Gonzaga, MD | |
|
2605 Development Dr, Green Bay, WI 54311-4240 | |
| (920) 288-8240 | |
| (920) 857-1488 |
| Full Name | Dr Teresa A Gonzaga |
|---|---|
| Gender | Female |
| Speciality | Plastic And Reconstructive Surgery |
| Experience | 16 Years |
| Location | 2605 Development Dr, Green Bay, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073776928 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2086S0122X | Surgery - Plastic And Reconstructive Surgery | 69135 (Wisconsin) | Secondary |
| 208200000X | Plastic Surgery | 69135 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Aurora Baycare Medical Ctr | Green bay, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Baycare Clinic Llp | 4385554328 | 185 |
News Archive
Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, today announced that Stellacure, GmbH, its stem cell company headquartered in Hamburg, Germany, has entered into an agreement with a licensee in Jordan to open an umbilical cord blood stem cell company in that Middle East nation.
The Board of Directors of Stereotaxis, Inc. announced today following its regularly scheduled board meeting that it reaffirmed the Company's plans for both the launch of the Epoch platform and expansion of the Odyssey platform into standard labs.
The scientists from Scripps Research, reveal a likely vulnerability or weakness of the coronavirus. An antibody, called CR3022, recovered from a survivor of the SARS outbreak in 2002, has shown a potential vulnerability of the novel coronavirus.
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that patient enrollment in the global pivotal Phase III clinical study CENTRIC has been completed.
› Verified 5 days ago
| Entity Name | Ascension Medical Group-southeast Wisconsin Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609881077 PECOS PAC ID: 8628980943 Enrollment ID: O20031104000421 |
News Archive
Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, today announced that Stellacure, GmbH, its stem cell company headquartered in Hamburg, Germany, has entered into an agreement with a licensee in Jordan to open an umbilical cord blood stem cell company in that Middle East nation.
The Board of Directors of Stereotaxis, Inc. announced today following its regularly scheduled board meeting that it reaffirmed the Company's plans for both the launch of the Epoch platform and expansion of the Odyssey platform into standard labs.
The scientists from Scripps Research, reveal a likely vulnerability or weakness of the coronavirus. An antibody, called CR3022, recovered from a survivor of the SARS outbreak in 2002, has shown a potential vulnerability of the novel coronavirus.
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that patient enrollment in the global pivotal Phase III clinical study CENTRIC has been completed.
› Verified 5 days ago
| Entity Name | Columbia St Marys Hospital Milwaukee Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023064482 PECOS PAC ID: 5890604722 Enrollment ID: O20031105000057 |
News Archive
Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, today announced that Stellacure, GmbH, its stem cell company headquartered in Hamburg, Germany, has entered into an agreement with a licensee in Jordan to open an umbilical cord blood stem cell company in that Middle East nation.
The Board of Directors of Stereotaxis, Inc. announced today following its regularly scheduled board meeting that it reaffirmed the Company's plans for both the launch of the Epoch platform and expansion of the Odyssey platform into standard labs.
The scientists from Scripps Research, reveal a likely vulnerability or weakness of the coronavirus. An antibody, called CR3022, recovered from a survivor of the SARS outbreak in 2002, has shown a potential vulnerability of the novel coronavirus.
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that patient enrollment in the global pivotal Phase III clinical study CENTRIC has been completed.
› Verified 5 days ago
| Entity Name | Baycare Clinic Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588609648 PECOS PAC ID: 4385554328 Enrollment ID: O20031105000087 |
News Archive
Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, today announced that Stellacure, GmbH, its stem cell company headquartered in Hamburg, Germany, has entered into an agreement with a licensee in Jordan to open an umbilical cord blood stem cell company in that Middle East nation.
The Board of Directors of Stereotaxis, Inc. announced today following its regularly scheduled board meeting that it reaffirmed the Company's plans for both the launch of the Epoch platform and expansion of the Odyssey platform into standard labs.
The scientists from Scripps Research, reveal a likely vulnerability or weakness of the coronavirus. An antibody, called CR3022, recovered from a survivor of the SARS outbreak in 2002, has shown a potential vulnerability of the novel coronavirus.
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that patient enrollment in the global pivotal Phase III clinical study CENTRIC has been completed.
› Verified 5 days ago
| Entity Name | Marshfield Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952347981 PECOS PAC ID: 2264345206 Enrollment ID: O20031106000590 |
News Archive
Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, today announced that Stellacure, GmbH, its stem cell company headquartered in Hamburg, Germany, has entered into an agreement with a licensee in Jordan to open an umbilical cord blood stem cell company in that Middle East nation.
The Board of Directors of Stereotaxis, Inc. announced today following its regularly scheduled board meeting that it reaffirmed the Company's plans for both the launch of the Epoch platform and expansion of the Odyssey platform into standard labs.
The scientists from Scripps Research, reveal a likely vulnerability or weakness of the coronavirus. An antibody, called CR3022, recovered from a survivor of the SARS outbreak in 2002, has shown a potential vulnerability of the novel coronavirus.
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that patient enrollment in the global pivotal Phase III clinical study CENTRIC has been completed.
› Verified 5 days ago
| Entity Name | Mchs Hospitals Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093221434 PECOS PAC ID: 5698071173 Enrollment ID: O20180208000096 |
News Archive
Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, today announced that Stellacure, GmbH, its stem cell company headquartered in Hamburg, Germany, has entered into an agreement with a licensee in Jordan to open an umbilical cord blood stem cell company in that Middle East nation.
The Board of Directors of Stereotaxis, Inc. announced today following its regularly scheduled board meeting that it reaffirmed the Company's plans for both the launch of the Epoch platform and expansion of the Odyssey platform into standard labs.
The scientists from Scripps Research, reveal a likely vulnerability or weakness of the coronavirus. An antibody, called CR3022, recovered from a survivor of the SARS outbreak in 2002, has shown a potential vulnerability of the novel coronavirus.
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that patient enrollment in the global pivotal Phase III clinical study CENTRIC has been completed.
› Verified 5 days ago
| Entity Name | Lakeview Medical Center Inc Of Rice Lake |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093201832 PECOS PAC ID: 6103737820 Enrollment ID: O20180817001484 |
News Archive
Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, today announced that Stellacure, GmbH, its stem cell company headquartered in Hamburg, Germany, has entered into an agreement with a licensee in Jordan to open an umbilical cord blood stem cell company in that Middle East nation.
The Board of Directors of Stereotaxis, Inc. announced today following its regularly scheduled board meeting that it reaffirmed the Company's plans for both the launch of the Epoch platform and expansion of the Odyssey platform into standard labs.
The scientists from Scripps Research, reveal a likely vulnerability or weakness of the coronavirus. An antibody, called CR3022, recovered from a survivor of the SARS outbreak in 2002, has shown a potential vulnerability of the novel coronavirus.
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that patient enrollment in the global pivotal Phase III clinical study CENTRIC has been completed.
› Verified 5 days ago
| Entity Name | Mchs Hospitals Inc |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1952890873 PECOS PAC ID: 5698071173 Enrollment ID: O20180904002962 |
News Archive
Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, today announced that Stellacure, GmbH, its stem cell company headquartered in Hamburg, Germany, has entered into an agreement with a licensee in Jordan to open an umbilical cord blood stem cell company in that Middle East nation.
The Board of Directors of Stereotaxis, Inc. announced today following its regularly scheduled board meeting that it reaffirmed the Company's plans for both the launch of the Epoch platform and expansion of the Odyssey platform into standard labs.
The scientists from Scripps Research, reveal a likely vulnerability or weakness of the coronavirus. An antibody, called CR3022, recovered from a survivor of the SARS outbreak in 2002, has shown a potential vulnerability of the novel coronavirus.
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that patient enrollment in the global pivotal Phase III clinical study CENTRIC has been completed.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Teresa A Gonzaga, MD 1035 Kepler Dr, Green Bay, WI 54311-8320 Ph: (920) 490-9046 | Dr Teresa A Gonzaga, MD 2605 Development Dr, Green Bay, WI 54311-4240 Ph: (920) 288-8240 |
News Archive
Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, today announced that Stellacure, GmbH, its stem cell company headquartered in Hamburg, Germany, has entered into an agreement with a licensee in Jordan to open an umbilical cord blood stem cell company in that Middle East nation.
The Board of Directors of Stereotaxis, Inc. announced today following its regularly scheduled board meeting that it reaffirmed the Company's plans for both the launch of the Epoch platform and expansion of the Odyssey platform into standard labs.
The scientists from Scripps Research, reveal a likely vulnerability or weakness of the coronavirus. An antibody, called CR3022, recovered from a survivor of the SARS outbreak in 2002, has shown a potential vulnerability of the novel coronavirus.
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that patient enrollment in the global pivotal Phase III clinical study CENTRIC has been completed.
› Verified 5 days ago
Dr. William J Dierberg, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2605 Development Dr, Green Bay, WI 54311 Phone: 920-288-8240 | |
Dr. James Lee, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 704 S Webster Ave, Ste 401, Green Bay, WI 54301 Phone: 920-436-8284 | |
Steven C Schmidt, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2605 Development Dr, Green Bay, WI 54311 Phone: 920-288-8240 Fax: 920-288-8255 | |
Dr. Elizabeth A O'connor, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2605 Development Dr, Green Bay, WI 54311 Phone: 920-288-8240 Fax: 920-288-8255 | |
Dr. Eugene H Schmitt Iii, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 704 S Webster Ave, Ste 401, Green Bay, WI 54301 Phone: 920-432-7000 Fax: 920-432-7451 | |
James M Zasuly, MD Plastic Surgery Medicare: Medicare Enrolled Practice Location: 2605 Development Dr, Green Bay, WI 54311 Phone: 920-288-8240 Fax: 920-857-1488 |